Why Pfizer Stock Slipped by 2% Today
On the surface, (NYSE: PFE) had some good news to report on Thursday. But investors viewed the positive as a negative, in light of its timing. This wasn't helped by an analyst's price-target cut on the stock.
At the end of the trading session, Pfizer's share price had declined by over 2%, versus the nearly 1% rise of the S 500 index.
The good news that few investors seemed impressed with had to do with Pfizer's COVID-19 drug Paxlovid. Thursday morning, the company announced that the treatment has been approved for use by adults with mild to moderate forms of the disease, and who are at high risk of progressing to severe forms.
Source Fool.com
Pfizer Inc. Stock
€20.90
-0.950%
We see a rather positive sentiment for Pfizer Inc. with 20 Buy predictions and 1 Sell predictions.
As a result the target price of 40 € shows a very positive potential of 91.43% compared to the current price of 20.9 € for Pfizer Inc..
